Global Critical Limb Ischemia Market Opportunities And Strategies 2023
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s critical limb ischemia market report forecasts the critical limb ischemia market size to grow to $4.62 Billion by 2027, with a CAGR (compound annual growth rate) of 8%.
Learn More On The Critical Limb Ischemia Market Report 2023 – https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report
Critical Limb Ischemia Market Size Forecast
The global critical limb ischemia market is expected to grow from $3.11 billion in 2022 to $3.39 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global critical limb ischemia treatment market size is expected to reach $4.62 billion in 2027 at a CAGR of 8.0%.
North America held the largest critical limb ischemia market share.
Key Critical Limb Ischemia Market Driver – Rise In Incidence Of Diabetes Mellitus And Peripheral Artery Diseases
According to the International Diabetes Federation, a Belgium-based umbrella organisation of national diabetes associations, the global diabetes prevalence in 20-79-year-olds was 536.6 million in 2021 and was anticipated to increase by 12.2% (783.2 million) in 2045. Furthermore, according to a journal released by Oxford University Press, a UK-based university press of the University of Oxford, in March 2023, more than 200 million people were affected by peripheral artery illnesses in 2020, and this figure is anticipated to rise by nearly 50% by 2045. As a result, the critical limb ischemia treatment market is being driven by the increasing adoption of cloud-based document processing services.
Request for A Sample Of The Global Critical Limb Ischemia Market Report:
Key Critical Limb Ischemia Market Trend – Technological Advancement
Major players in the critical limb ischemia therapy market are implementing new technologies to increase their market position. The Society for Vascular Surgery (SVS), a major national academic vascular surgery society in the United States, for example, launched three new mobile applications related to chronic limb-threatening ischemia treatment in January 2021: the VQI CLTI Mortality Prediction Model, the SVS Threatened Limb Classification [WIfI] calculator, and the Global Limb Anatomic Staging System [GLASS] calculator. They are specially built programmes that assist physicians in the treatment and management of chronic limb-threatening illnesses, allowing real-time calculation of patient risk, severity of limb threat, and disease anatomic complexity.
Critical Limb Ischemia Market Segment
1) By Type: Devices, Drugs, Surgery
2) By Medication: Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Other Medications
3) By Application: Hospital, Clinic, Other Applications
Critical Limb Ischemia Market Major Players and Strategies
Major players in the critical limb ischemia market are Medtronic Plc, Boston Scientific Corporation, ThermoGenesis Holdings Inc., Abbott Laboratories, Pluri Biotech Ltd., Rexgenero Ltd., LimFlow SA, Micro Medical Solutions, Cardiovascular Systems Inc., Cynata Therapeutics Ltd, Shanghai MicroPort Medical (Group) Co Ltd., B. Braun SE, Biotronik SE & Co KG, Teva Pharmaceutical Industries Ltd., and Aldagen Inc.
Cardiovascular Systems Inc., a medical device firm based in the United States, announced an investment and purchase option with CarePICS LLC in April 2021 for an unknown sum. In this transaction, CSI invested in CarePICS’ data-driven solution and digital SaaS product, both of which are designed to improve patient outcomes. CarePICS is a telehealth startup established in the United States that provides a virtual care platform to improve the outcomes of patients suffering from critical limb ischemia (CLI).
The Critical Limb Ischemia Global Market Report 2023 covers regional data on critical limb ischemia market size, critical limb ischemia market trends and drivers, opportunities, strategies, and critical limb ischemia market competitor analysis. The countries covered in the critical limb ischemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Critical limb ischemia treatment is restoring blood flow to the affected area. Critical limb ischemia is a chronic condition in which blood supply to one or both of the hands and legs is severely obstructed, resulting in numbness and pain. Treatment entails diagnosing and treating patients using medication, surgery with gadgets, and other methods.
View More Reports Related To The Critical Limb Ischemia Market –
Critical Illness Insurance Global Market Report 2023
Critical Care Equipment Global Market Report 2023
Cardiac Biomarkers Testing Global Market Report 2023
Follow us on:
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: